Company Information

  

Address: C/O MOURANT OZANNES CORPORATE SERVICES
94 SOLARIS AVENUE, CAMANA BAY 
City: GRAND CAYMAN 
State:  
Zip Code: KY1-1108 
Telephone: 13459494123 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

We are a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
03/2018-0.23NAN/E
12/2017-0.17NAN/E
09/2017-0.08NAN/E
06/2017-0.39NAN/E
03/2017-0.33NAN/E
12/2016-0.30NAN/E
09/2016-0.07NAN/E
06/2016-0.02NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.09Total Liab/Total Assets0.36
Net Inc/Total Assets-0.09Total Liab/Inv Cap0.42
Net Inc/Inv Cap-0.10Total Liab/Comm Equity0.38
Pretax Inc/Net Sales-0.38Interest Coverage RatioNA
Net Inc/Net Sales-0.39Curr Debt/Equity0.01
Cash Flow/Net Sales0.05LTD/Equity0.23
SG&A/NetSales0.26Total Debt/Equity0.25
Asset Utilization   Liquidity  
Net Receivables Turnover16.20Quick Ratio6.02
Inventory Turnover0.91Current Ratio6.09
Inventory Day Sales0.00Net Rec/Curr Assets0.03
Net Sales/Work Cap0.31Inv/Curr Assets0.01
Net Sales/PP&E3.81  

Income Statement (Millions)

  3/31/2018 12/31/2017 9/30/2017 6/30/2017
Total Revenues(Net Sales) 32.54 18.17 220.21 0.00
Cost of Goods Sold 4.55 3.03 1.94 0.00
Selling & Admin Exps 28.92 27.42 15.64 10.78
Operating Income -110.81 -103.80 114.91 -58.02
Interest Exp NA NA NA NA
Pretax Income -108.53 -94.37 114.22 -60.48
Other Income 2.28 9.96 1.10 -0.66
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -104.60 -99.32 117.39 -60.55

Balance Sheet (Millions)

Assets 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Cash & Short Term Investments 1,481.48 837.52 757.44 407.43
Receivables - Total 47.35 29.43 181.47 NA
Inventories - Total 7.50 10.93 5.71 NA
Total Current Assets 1,585.70 913.50 962.33 418.69
Net Property, Plant & Equipment 76.99 62.57 55.32 33.77
Total Assets 1,708.93 1,046.48 1,049.06 473.98
Liabilities        
Accounts Payable 118.32 128.53 85.01 49.95
Debt in Current Liabilities 9.57 9.22 9.02 NA
Total Current Liabilities 141.90 149.99 103.16 49.95
Long-Term Debt 164.12 155.49 149.33 152.73
Total Liabilities 364.55 376.67 298.92 218.22
Stockholder's Equity        
Minority Interest 14.34 14.42 14.35 14.42
Preferred Stock NA NA NA NA
Common Stock 0.07 0.06 0.06 0.05
Retained Earnings -438.04 -330.52 -231.19 -348.58
Treasury Stock NA NA NA NA
Total Stockholders' Equity 1,344.38 669.81 750.14 255.75
Total Liabilities and Stockholders' Equity 1,708.93 1,046.48 1,049.06 473.98

Cash Flow Summary (Millions)

Categories 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Net Cash Provided by Operating Activities -104.50 93.75 6.60 -51.89
Net Cash Provided by Investing Activities -394.35 -68.24 -401.33 69.71
Net Cash Provided by Financing Activities 763.90 3.05 339.71 145.07

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/201311.15-7.49--
12/201413.04-18.28--
12/20158.82-57.10--
12/20161.07-119.22-0.30
12/2017238.39-93.10-0.17
Growth Rates115.04----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/1813436,2905.19




Report Date : 7/16/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.